Literature DB >> 19692686

Multinational medicines--ensuring drug quality in an era of global manufacturing.

Susan Okie1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19692686     DOI： 10.1056/NEJMp0903870

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Comment on: Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe by Johnston et al.

Authors:  John B Warren; Kersti Oselin
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

Review 2.  Generics, chemisimilars and biosimilars: is clinical testing fit for purpose?

Authors:  John B Warren
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

3.  Making individualized drugs a reality.

Authors:  Huub Schellekens; Mohammed Aldosari; Herre Talsma; Enrico Mastrobattista
Journal:  Nat Biotechnol       Date:  2017-06-05       Impact factor: 54.908

4.  Key person ethical decision-making and substandard drugs rejection intentions.

Authors:  Xiaohong Ren; Xiaoyan Wang; He Sun
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.